Related references
Note: Only part of the references are listed.The methylation hypothesis of pharmacoresistance in epilepsy
Katja Kobow et al.
EPILEPSIA (2013)
The transport of antiepileptic drugs by P-glycoprotein
Chunbo Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy
Marion Bankstahl et al.
EXPERIMENTAL NEUROLOGY (2012)
Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected
Wolfgang Loescher et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials
Philippe Ryvlin et al.
LANCET NEUROLOGY (2011)
Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus
Nicole A. Hawkins et al.
NEUROBIOLOGY OF DISEASE (2011)
CURRENT CONCEPTS Drug-Resistant Epilepsy
Patrick Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility
Benjamin S. Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs
Wolfgang Loescher
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Pharmacoresistant epilepsy: From pathogenesis to current and emerging therapies
Sandipan Pati et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2010)
High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy
Wolfgang Loescher et al.
EPILEPSIA (2010)
Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466
Brita Fritsch et al.
EPILEPSIA (2010)
Altered Function of the SCN1A Voltage-gated Sodium Channel Leads to γ-Aminobutyric Acid-ergic (GABAergic) Interneuron Abnormalities
Melinda S. Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects
Miriam H. Meisler et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Antiepileptic drug therapy the story so far
Martin J. Brodie
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
Identification of Pharmacoresistant Epilepsy
Anne T. Berg
NEUROLOGIC CLINICS (2009)
Neurosteroid Replacement Therapy for Catamenial Epilepsy
Doodipala S. Reddy et al.
NEUROTHERAPEUTICS (2009)
NEW DEVELOPMENTS IN ANTIEPILEPTIC DRUG RESISTANCE: AN INTEGRATIVE VIEW
Dieter Schmidt et al.
EPILEPSY CURRENTS (2009)
A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy
Fritz Zimprich et al.
EPILEPSIA (2008)
Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs
Claude G. Wasterlain et al.
EPILEPSIA (2008)
Quality-of-life trajectories in epilepsy: A review of the literature
Ann Jacoby et al.
EPILEPSY & BEHAVIOR (2008)
Antiepileptic Drug Transport—Of Mice and Men
Graeme J. Sills
Epilepsy Currents (2008)
Intrinsic Severity as a Determinant of Antiepileptic Drug Refractoriness
Michael A. Rogawski et al.
Epilepsy Currents (2008)
The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy
Melinda S. Martin et al.
HUMAN MOLECULAR GENETICS (2007)
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy
Anna L. Luciano et al.
ANNALS OF NEUROLOGY (2007)
Likelihood of seizure remission in an adult population with refractory epilepsy
Brian C. Callaghan et al.
ANNALS OF NEUROLOGY (2007)
Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy
Christina Schaub et al.
EPILEPSIA (2007)
Predictors of pharmacoresistant epilepsy
Nikolas Hitiris et al.
EPILEPSY RESEARCH (2007)
Molecular targets for antiepileptic drug development
Brian S. Meldrum et al.
NEUROTHERAPEUTICS (2007)
New-onset temporal lobe epilepsy in children - Lesion on MRI predicts poor seizure outcome
C. G. Spooner et al.
NEUROLOGY (2006)
The multidrug transporter hypothesis of drug resistance in epilepsy:: Proof-of-principle in a rat model of temporal lobe epilepsy
Claudia Brandt et al.
NEUROBIOLOGY OF DISEASE (2006)
A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose
Sarah K. Tate et al.
PHARMACOGENETICS AND GENOMICS (2006)
Clinical predictors of intractable childhood epilepsy
Aithala Gururaj et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2006)
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response:: a prospective cohort study
Guy Leschziner et al.
LANCET NEUROLOGY (2006)
Clinical spectrum of mutations in SCN1A gene: Severe myoclonic epilepsy in infancy and related epilepsies
Tateki Fujiwara
EPILEPSY RESEARCH (2006)
Cognitive prognosis in chronic temporal lobe epilepsy
Bruce P. Hermann et al.
ANNALS OF NEUROLOGY (2006)
Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats
EA van Vliet et al.
EPILEPSIA (2006)
Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2
JA Kearney et al.
HUMAN MOLECULAR GENETICS (2006)
Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABAA receptor ligand binding in a model of temporal lobe epilepsy
HA Volk et al.
NEUROBIOLOGY OF DISEASE (2006)
Factors predictive of outcome in childhood epilepsy
M Oskoui et al.
JOURNAL OF CHILD NEUROLOGY (2005)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin
SK Tate et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mortality of epilepsy in developed countries: A review
L Forsgren et al.
EPILEPSIA (2005)
The influence of comorbid depression on seizure severity
JA Cramer et al.
EPILEPSIA (2003)
Early predictors of medical intractability in childhood epilepsy
KL Kwong et al.
PEDIATRIC NEUROLOGY (2003)
Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats
S Remy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
A novel mechanism underlying drug resistance in chronic epilepsy
S Remy et al.
ANNALS OF NEUROLOGY (2003)
Psychosocial reactions to the epilepsy in an unselected group of patients with epilepsy under treatment in general hospitals
AP Aldenkamp et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2003)
Etiology and clinical predictors of intractable epilepsy
S Chawla et al.
PEDIATRIC NEUROLOGY (2002)
Role of multidrug transporters in pharmacoresistance to antiepileptic drugs
W Löscher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy
SM Sisodiya et al.
BRAIN (2002)
Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats
M Jeub et al.
NEUROPHARMACOLOGY (2002)
Refractory epilepsy: a progressive, intractable but preventable condition?
P Kwan et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2002)
Early development of intractable epilepsy in children - A prospective study
AT Berg et al.
NEUROLOGY (2001)
Neurosteroid withdrawal model of perimenstrual catamenial epilepsy
DS Reddy et al.
EPILEPSIA (2001)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Health status of people with epilepsy compared with a general reference population
K Stavem et al.
EPILEPSIA (2000)
Share Paper
